Enrico De Vita1,2, Andrew Melbourne3, Marie-Claire Porter4,5, David L Thomas6, Sebastien Ourselin3, Tarek Yousry1,2, Xavier Golay2, Rolf Jager1,2, Simon Mead4,5, and John S Thornton1,2
1Lysholm Department of Neuroradiology, National Hospital for Neurology and Neurosurgery, London, United Kingdom, 2Academic Neuroradiological Unit. Department of Brain Repair and Rehabilitation, UCL Institute of Neurology, London, United Kingdom, 3Medical Physics and Biomedical Engineering, University College London, London, United Kingdom, 4National Prion Clinic, National Hospital for Neurology and Neurosurgery, London, United Kingdom, 5MRC Prion Unit, Department of Neurodegenerative Diseases, UCL Institute of Neurology, London, United Kingdom, 6Dementia Research Centre, UCL Institute of Neurology, London, United Kingdom
Synopsis
Perfusion in Prion disease has only been explored with SPECT, except in 2 single-case studies.
We aimed
to evaluate perfusion abnormalities with ASL-MRI in prion patients and compare the
findings with clinically diagnostic high b-value diffusion weighted MRI. We observed high correlation between diffusion abnormalities and hypoperfusion. ASL-MRI could help to shed light non-invasively on the neurovascular aspects of prion disease
Introduction
and Purpose
Prion disease is a progressive, uniformly fatal
neurodegenerative disease caused by the accumulation of abnormal prion proteins
in the brain. Diffusion-weighted imaging (DWI) is one of the most sensitive MRI
techniques for differential diagnosis of prion disease, often showing
hyperintensities in basal ganglia and selected cortical regions, with
high-b-value DWI being preferable
1. Most perfusion studies in prion
disease were performed with SPECT and described diffuse patterns of
hypoperfusion, often matching the MRI findings
2. Given the spatial-resolution
limitations of SPECT, MRI measurements could aid in further characterising the
progression of prion disease and its effect on local brain perfusion. However, the
related literature is scarce with a single example of CBV estimation using
Gadolinium-enhanced MRI perfusion
3 and 2 single-case reports using arterial
spin labelling (ASL)
4-5. We aimed to evaluate perfusion
abnormalities with ASL-MRI in prion patients and compare the findings with
clinically diagnostic high b-value diffusion weighted MRI.
Materials and Methods
Six prion disease patients (2 sporadic CJD –sCJD, 3 inherited;
median age 56 years, range 31-72,) and 13 healthy subjects (49, 38-75 years) were
scanned after informed consent on a 3T Siemens Trio. DWI with b=3000 s/mm
2
was performed with a 3-scan trace measurement (resolution 1x1x5 mm3).
FAIR Q2TIPS pulsed ASL used a 8-segment 3DGRASE readout with background
suppression
6; parameters were: spatial resolution 3.75x3.75x5mm
3;
TR=4s; TI1/2=800/2000ms; 5-9 repetitions; single M0 image. B0-field maps were
acquired for geometric distortion correction. Structural T1-weighted (T1W)
acquisition used MPRAGE. All subjects were clinically evaluated with the MRC
scale score, assessing a number of cognitive/functional domains (20=normal,
decreasing with progression)
7.
Perfusion was quantified as in the ASL White paper
8.
Distortion corrected DWI images were affine-registered in ASL space. Areas of hyper-intensity
were drawn on ASL-registered DWI images.
T1-W images were simultaneously
segmented/parcellated
9, and a population group-wise space estimated
10. By registering the ASL data to the
group-template, a ‘normal perfusion’ template was obtained. Patients’ ROIs were
‘transformed’ to the group-template space, to compare individual patient ROI
CBF to control values. To evaluate regional differences, CBF maps were also
normalised setting mean cortical GM CBF to 50ml/100g/min (normCBF). CBF and
normCBF were evaluated in 6 areas per hemisphere: frontal, temporal, parietal,
occipital lobes, plus cingular and insular cortex. CBF and normCBF Z scores (based
on controls standard deviation) were calculated for patients and are noted for
Z≤-2.0.
Results
Patients details are
in Figure 1. Figure 2 shows (a) healthy DWI images, (b),(c),(d) DWI and
corresponding CBF for 3 patients, (e) mean control CBF. Figure 3 illustrates the main ROI findings. Patients had lower
median cortical GM than controls. Patients 1 and 2 did not show focal
abnormalities on DWI or structural imaging, nor obvious abnormalities or
asymmetry on CBF. Patient 1 had high mean cortical GM compared vs controls. For patient 2, normCBF was
low in parietal lobes. Patients 3, 4, 5 had clear hyperintensities on DWI. All
these areas also showed reduced ADC. Qualitatively, the CBF maps showed
hypoperfusion in the same areas, in some cases with an exact overlap; in other
cases there was a slight mismatch (see Fig.
2b,c,d). Whilst cortical perfusion abnormalities were very obvious, basal
ganglia hypoperfusion was slightly harder to detect on the CBF maps. Patient 3 (Fig. 2b) had normCBF reductions
matching the overall observation of more prominent left hemisphere involvement.
Patient 4 (Fig. 2c) had a severely
abnormal CBF map, with very high CBF in the areas of hyperintense DWI (see
caption). Patient 5 (Fig. 2d) showed
low normCBF mostly in the left parietal and cingulate cortex.
Discussion and Conclusions
Prion patients often
present with clear MRI signs at time of diagnosis, most often restricted
diffusion on DWI. In some cases concomitant hypoperfusion assessed by SPECT has
been reported
11. We report ASL-CBF measurements on 5 prion patients.
In cases with clear DWI hyperintensities, there were definite and well
correlated CBF reductions. Manual delineation of ROIs confirmed visual
assessment of CBF maps by providing comparison to control values. Evaluation of
normCBF over the main cerebral lobes also helped to highlight diffuse perfusion
deficiencies.
The histological
hallmarks of prion are spongiosis, neuronal loss and gliosis, the combination
of which results in diffusion changes. Some investigators reported a non
monotonous change in ADC in some patients
12 probably
reflecting the time-varying relative contribution of these mechanisms.
ASL perfusion appears
to be able to reproduce the previous finding obtained in prion disease with
SPECT. Its non-invasive nature makes it viable for serial assessments and
coupled with DWI it could allow further characterisation of the neurovascular
aspects of the disease.
Acknowledgements
Part
of this work was undertaken at UCLH/UCL who received a proportion of funding
from the Department of Health’s NIHR Biomedical Research Centres funding
scheme. DLT is supported by the UCL Leonard Wolfson
Experimental Neurology Centre (PR/ylr/18575).References
1. Hyare 2010, AJNR, 31:521.
2.
Henkel 1999, J
Neurol 1999;
246(S1): 490.
3. Romano 2007, Neuroradiolog
20(1):56.
4. Prasad 2010, J Neuro-Ophthalm; 30:1.
5. Chen 2015, J Clin Neuroscience; 22: 204.
6. Gunther 2005. MRM 54(2):491.
7.
Thompson 2013, Brain, 136(Pt 4):1116.
8. Alsop 2014, MRM, 73(1):102.
9. Cardoso 2015, IEEE Trans Med
Imaging, 34:1976.
10. Modat 2010, Comput Methods Programs Biomed, 98(3):278.
11.
Na 1999 Arch Neurol, 56:951.
12. Tschampa 2003, AJNR, 24:908.